Podcast

ASCRS 2020: OSD improvement in eyes implanted with trabecular meshwork bypass stents

Author(s):

Alex Delaney-Gesing
Conferences|ASCRS

John Berdahl, MD, of Vance Thompson Vision, speaks with Ophthalmology Times'® David Hutton on the highlights of his presentation "Ocular Surface Disease Improvement in Eyes Implanted with Trabecular Meshwork Bypass Stents (iStent or iStent inject)," during the 2020 ASCR virtual meeting.

See more ASCRS coverage

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
Related Content
What the eyes reveal: Cardiovascular clues in women—hidden in plain sight
August 14th 2025

What the eyes reveal: Cardiovascular clues in women—hidden in plain sight

Evaluating safety, efficacy of TP03 for Demodex blepharitis treatment
August 14th 2025

Evaluating safety, efficacy of TP03 for Demodex blepharitis treatment

Targeted therapies improve care for Demodex blepharitis and OSD
August 14th 2025

Targeted therapies improve care for Demodex blepharitis and OSD

EyePod
August 14th 2025

ASCRS 2020: Assessing aberration of monofocal toric IOL with enhanced optic recovery, alignment

(Image credit: AdobeStock/frender) Q&A: Brandon D. Ayres, MD, on streamlining anterior vitrectomy with a high-speed, small-gauge probe at ASCRS 2025
August 14th 2025

Q&A: Brandon D. Ayres, MD, on streamlining anterior vitrectomy with a high-speed, small-gauge probe at ASCRS 2025

Q&A: Eva Kim, MD, on the value of EVO ICL for patients considering surgery
August 14th 2025

Q&A: Eva Kim, MD, on the value of EVO ICL for patients considering surgery

© 2025 MJH Life Sciences

All rights reserved.